Latest news and research on all cancers and treatments, updated several times a week, plus 10,000-item data base of these
Researchers who have harnessed the body's immune system to fight cancer have found a way to make the approach work even better, using an ...
New research suggests that patients recovering from bowel cancer surgery may be at a higher risk of relapse if their blood shows an immune ...
They work by interfering with the way cancer cells use signals to hide from the body's immune system. Some cancer cells send a message to the ...
U.K. Regulators Grant Early Access to Merck Skin Cancer Drug, but Where Is Northwest Bio? - TheStreet.com
I know after patients receive a diagnosis of cancer, they feel stress and ... ourimmune system can predispose individuals to illnesses and even cancer.
"We already know that frequent massage can enhance the immune system and reduce anxiety, and it has been reported that massage therapy can ...
“Unituxin is a new therapy that tricks the body into recognizing the cancer has foreign and attacks it with the tools of the child's own immune system.”.
“We will be evaluating the interaction between the cancer cell and the immune system, and that will tell us what to do.” In other words, clinicians will ...
FDA Gives Nod to CDK-4/6 Inhibitor for Breast Cancer
The approval stipulates use of palbociclib in combination with letrozole (Femara) in patients with metastatic breast cancer who have received no prior endocrine therapy. The FDA previously designated palbociclib for breakthrough therapy status, which put the drug on the fast track to approval.
The approval stipulates use of palbociclib in combination with letrozole (Femara) in patients with metastatic breast cancer who have received no prior endocrine therapy. The FDA previously designated palbociclib for breakthrough therapy status, which put the drug on the fast track to approval.
FDA Approves Dinutuximab (Unituxin) for Pediatric Neuroblastoma
The US Food and Drug Administration has approved dinutuximab (Unituxin) for the treatment of high-risk neuroblastoma in pediatric patients.
The US Food and Drug Administration has approved dinutuximab (Unituxin) for the treatment of high-risk neuroblastoma in pediatric patients.
Lower Colorectal Cancer Risk With Pescovegetarian and Vegetarian Diets
In a large study, it was found that those who ate a vegetarian diet had a lower risk of colorectal cancer compared with their non-vegetarian counterparts.
In a large study, it was found that those who ate a vegetarian diet had a lower risk of colorectal cancer compared with their non-vegetarian counterparts.
According to Srinivas, metastatic bladder cancer treated with platinum-based combination chemotherapy results in a response rate of between 45% ...
"We have over 800 samples from more than 300 bladder cancer patients," says Anne. The team takes tiny pieces of these tumour samples – known as ...
With the exception of urinary bladder cancer, invasive cancer is defined as cancer that has spread to surrounding normal tissue from where it began.
Immunotherapy with drugs that act on the program death (PD) pathway offers a novel approach to the treatment of non–small cell lung cancer ...
| Science AAAS |
Now researchers have found a genetic signature within lung tumors that seems to predict whether this immunotherapy drug will work—and who will ...
CT scans of David Bolgiano's lungs: At the time of his immunotherapy treatment (first ... (Abramson Cancer Center of the University of Pennsylvania).
A study led by Duke Cancer Institute researchers demonstrated that an innovative pretreatment can enhance the effectiveness of immunotherapy for ...
Dramatic Patient Survival Benefit Shown for New Approach to Treating Glioblastoma Multiforme ... -PipelineReview.com (press release)
BALTIMORE, MD / ACCESSWIRE / March 12, 2015 / Cancer immunotherapy has become today's word for treating patients with death-causing ...
The Phase III study named, Xilonix™ Colorectal cancer Immunotherapy Treatment Evaluation ("XCITE"), assesses XBiotech's True Human™ ...
... is a well known anti cancer drug currently in use for many cancers including ovarian cancer, breast cancer, lung cancer and pancreatic cancer.
Science Daily Cancer News
Scientists are eager to make use of stem cells' extraordinary power to transform into nearly any kind of cell, but that ability also is cause for concern in cancer treatment. A new study shows stem cells are found even in low-grade tumors, where they can resist treatment.
Increasing colorectal cancer screening rates to 80 percent by 2018 would prevent an additional 21,000 colorectal cancer deaths per year by 2030, according to a new study.
Patients with low-risk prostate or breast cancer were more likely to receive inappropriate imaging during treatment, based on the region of the country in which they received medical care, a report has shown.
A surgical approach in which a surgeon removes less than a lobe of the liver in a patient undergoing an operation for liver cancer is associated with lower mortality and complication rates, according to new study.
Very low mammographic breast density worsens the prognosis of breast cancer, according to a recent study. Disease free survivals, as well as overall life expectancies, were significantly shorter in women with very low-density breasts in comparison to women with high density breast tissue. The lower the breast tissue density, the less fibroglandular tissue there is compared to fat tissue.
Tambahkan Komentar